NCT02078817View on ClinicalTrials.gov

Ketamine in Adolescents With Treatment-Resistant Depression

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Major Depressive Disorder
Interventions
DRUG

Ketamine

IV infusions of 0.5mg/kg of Ketamine hydrochloride over a 40-minute infusion period. Participants will receive a total of 6 doses over a 2-week period.

Trial Locations (1)

55454

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT02078817 - Ketamine in Adolescents With Treatment-Resistant Depression | Biotech Hunter | Biotech Hunter